TRT Side Effects: What Can Change Early, What Matters Long Term, and What We Still Don’t Know

What TRT actually does

Testosterone replacement therapy supplies testosterone from outside the body — as a gel, injection, patch or pellet — to raise circulating levels in men with diagnosed deficiency.

Because the body regulates testosterone through a feedback loop between the brain and the testes, supplying it externally reduces the brain’s signal to produce it internally. That is not a side effect in the incidental sense; it is a direct consequence of how the axis works, and it underlies several of the effects below.

This is categorically different from nutritional support. TRT is a prescription hormone. A supplement is not, and does not act by the same mechanism.

What can change early

Effects vary by individual, dose and formulation, and none of the following is universal. They are the things clinicians typically monitor.

• —Hematocrit and red blood cell count can rise, sometimes enough to require dose adjustment, a change in formulation or, occasionally, treatment interruption.
• —Skin changes including acne and oily skin are relatively common early.
• —Blood pressure can increase; this is a specific focus of current regulatory labelling.
• —Sperm production is typically suppressed, with implications for fertility.
• —Breast tenderness or gynaecomastia can occur in some men.
• —Prostate and urinary symptoms are monitored, with PSA assessment as clinically indicated.
• —Injection-site or application-site reactions, and transfer risk with topical gels.

The fertility question deserves attention before treatment

Exogenous testosterone suppresses the hormonal signalling that drives the testes’ own testosterone production and spermatogenesis. Sperm counts commonly fall substantially, and in some men to zero, during treatment.

Recovery of sperm production after stopping is possible and often occurs, but it is variable and can take many months. Reviews of spermatogenesis recovery after exogenous testosterone describe a range of timelines and outcomes rather than a guaranteed return to baseline.

So neither internet claim holds. TRT does not automatically make a man permanently infertile, and it cannot be promised that fertility will fully return. If future fertility matters to you, that conversation belongs before treatment starts, with a clinician who can discuss alternatives, baseline semen analysis and sperm banking.

The cardiovascular story changed

For a decade, cardiovascular safety was the central unresolved question in testosterone therapy, driven by conflicting observational data and a 2015 regulatory warning.

TRAVERSE, published in the New England Journal of Medicine in 2023, was the large randomised placebo-controlled safety trial the field had been waiting for: middle-aged and older men with hypogonadism and either existing cardiovascular disease or high risk of it, followed on testosterone gel or placebo. Testosterone was noninferior to placebo for the primary endpoint of major adverse cardiac events — cardiovascular death, non-fatal myocardial infarction and non-fatal stroke.

The secondary observations were not empty. Higher incidences of atrial fibrillation, acute kidney injury and pulmonary embolism were observed in the testosterone group, and these remain relevant to clinical decision-making.

In 2025 the FDA updated labelling for testosterone products in light of the cardiovascular evidence, while adding emphasis on the risk of blood-pressure increases. The direction of travel is more precise labelling, not a clean bill of health.

Long term does not mean fully known

TRAVERSE followed men for a period measured in years. Many men who begin TRT in their forties may be treated for decades.

Endocrine Society guidance continues to emphasise accurate diagnosis, appropriate patient selection and structured monitoring, and to note that important long-term questions — including outcomes over very long treatment durations — remain open.

That is an uncomfortable answer for a topic where everyone wants certainty, but it is the accurate one. “Not shown to increase major cardiac events over the trial period” is a meaningful finding. It is not the same statement as “safe indefinitely”.

The fracture result nobody expected

Testosterone supports bone mineral density, so a fracture substudy of TRAVERSE was widely expected to show fewer fractures in the treated group.

It did not. Clinical fracture incidence was numerically higher in the testosterone group than in placebo.

This should not be read as proof that testosterone causes fractures. It was a substudy, the mechanism is unclear, and increased physical activity in treated men is one of several proposed explanations. It is best understood as a demonstration of why large long-term randomised trials exist: a mechanism can point convincingly in one direction and the outcome can still land somewhere else.

TRT and natural support are not interchangeable

It is worth stating the distinction plainly, because a great deal of supplement marketing depends on blurring it.

Natural nutritional support supplies nutrients and botanicals intended to support the body’s own physiology — vitamin D, zinc, magnesium and researched botanicals, at amounts studied in humans. TRT supplies exogenous testosterone as prescription hormone replacement for a diagnosed medical condition.

One is not a substitute for the other where medical treatment is indicated. ROWR is a food supplement system. It does not treat hypogonadism, and if you have been prescribed TRT you should not stop, start, pause or change it based on anything written here. That decision belongs to you and the clinician managing your care.

Before reducing fatigue to “low T”

Much of the traffic toward TRT begins with fatigue. That is worth slowing down over, because fatigue is one of the least specific symptoms in medicine.

In the Testosterone Trials, raising testosterone in older men with low levels did not significantly improve the primary vitality outcome. Sleep, energy intake, training load, thyroid function, iron status and sleep apnoea all belong in the conversation.

A properly timed repeat test, an honest look at sleep and recovery, and a clinician who investigates rather than prescribes on the first reading is a better starting sequence than any article on the internet — including this one.